Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $14,749 | 1,066 | 98.6% |
| Education | $213.95 | 18 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,288 | 152 | $0 (2024) |
| Novo Nordisk Inc | $1,932 | 185 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,155 | 58 | $0 (2024) |
| PFIZER INC. | $1,006 | 96 | $0 (2024) |
| GlaxoSmithKline, LLC. | $747.52 | 58 | $0 (2023) |
| Lilly USA, LLC | $666.05 | 56 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $606.20 | 44 | $0 (2024) |
| Merck Sharp & Dohme LLC | $594.65 | 66 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $587.75 | 34 | $0 (2024) |
| Amarin Pharma Inc. | $485.03 | 32 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,441 | 80 | ABBVIE INC. ($564.66) |
| 2023 | $2,760 | 162 | ABBVIE INC. ($917.93) |
| 2022 | $1,869 | 122 | ABBVIE INC. ($346.14) |
| 2021 | $1,667 | 145 | AbbVie Inc. ($378.89) |
| 2020 | $1,034 | 69 | Amarin Pharma Inc. ($213.48) |
| 2019 | $2,309 | 166 | Novo Nordisk Inc ($555.73) |
| 2018 | $1,615 | 139 | Novo Nordisk Inc ($436.75) |
| 2017 | $2,269 | 201 | Novo Nordisk Inc ($334.90) |
All Payment Transactions
1,084 individual payment records from CMS Open Payments — Page 1 of 44
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Biological | ||||||
| 08/29/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: Respiratory | ||||||
| 08/27/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/08/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Neuroscience | ||||||
| 08/06/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: Diabetes | ||||||
| 08/01/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $21.62 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/25/2024 | ABBVIE INC. | CREON (Drug), LINZESS | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/24/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $20.40 | General |
| Category: Respiratory | ||||||
| 07/23/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $33.91 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 07/23/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.92 | General |
| Category: NEUROSCIENCE | ||||||
| 07/22/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.50 | General |
| Category: Oncology | ||||||
| 07/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.00 | General |
| Category: NEUROSCIENCE | ||||||
| 07/18/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $20.25 | General |
| Category: NEUROLOGY | ||||||
| 07/16/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.21 | General |
| Category: NEUROSCIENCE | ||||||
| 07/12/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $23.06 | General |
| Category: PSYCHIATRY | ||||||
| 07/02/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $24.62 | General |
| Category: NEUROSCIENCE | ||||||
| 06/28/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $19.19 | General |
| Category: PSYCHIATRY | ||||||
| 06/28/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Neuroscience | ||||||
| 06/26/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $10.96 | General |
| Category: NEUROSCIENCE | ||||||
| 06/25/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/21/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.19 | General |
| Category: Diabetes | ||||||
| 06/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: DIABETES | ||||||
| 06/07/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/07/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $7.06 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 473 | 817 | $82,162 | $38,713 |
| 2022 | 4 | 481 | 811 | $79,934 | $40,244 |
| 2021 | 3 | 505 | 972 | $86,977 | $44,556 |
| 2020 | 4 | 549 | 1,032 | $88,189 | $37,712 |
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 260 | 501 | $47,094 | $19,299 | 41.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 181 | 278 | $28,078 | $18,123 | 64.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 19 | 22 | $3,454 | $874.94 | 25.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 13 | 16 | $3,536 | $415.98 | 11.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 280 | 530 | $49,820 | $24,096 | 48.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 165 | 239 | $24,139 | $14,760 | 61.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 12 | 15 | $3,188 | $677.46 | 21.3% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 13 | 16 | $2,512 | $652.37 | 26.0% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2022 | 11 | 11 | $275.00 | $58.26 | 21.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 321 | 719 | $58,034 | $29,248 | 50.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 154 | 212 | $21,874 | $13,997 | 64.0% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 19 | 21 | $3,297 | $741.24 | 22.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 11 | 20 | $3,772 | $569.65 | 15.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 310 | 667 | $46,690 | $21,056 | 45.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 184 | 278 | $30,024 | $14,166 | 47.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 16 | 25 | $3,725 | $788.30 | 21.2% |
| G0180 | Physician certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial implem | Office | 2020 | 16 | 19 | $2,983 | $663.36 | 22.2% |
| G0179 | Physician re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial imp | Office | 2020 | 12 | 25 | $825.00 | $523.97 | 63.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 11 | 18 | $3,942 | $514.13 | 13.0% |
About Dr. Gordon Long, M.D
Dr. Gordon Long, M.D is a Family Medicine healthcare provider based in Ontario, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1487769766.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Gordon Long, M.D has received a total of $14,963 in payments from pharmaceutical and medical device companies, with $1,441 received in 2024. These payments were reported across 1,084 transactions from 61 companies. The most common payment nature is "Food and Beverage" ($14,749).
As a Medicare-enrolled provider, Long has provided services to 2,008 Medicare beneficiaries, totaling 3,632 services with total Medicare billing of $161,225. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Ontario, OH
- Active Since 08/20/2006
- Last Updated 07/05/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1487769766
Products in Payments
- UBRELVY (Drug) $859.44
- NURTEC ODT (Drug) $608.22
- Ozempic (Drug) $587.56
- JARDIANCE (Drug) $571.65
- VRAYLAR (Drug) $554.06
- REXULTI (Drug) $530.51
- FARXIGA (Drug) $488.46
- Vascepa (Drug) $485.03
- QULIPTA (Drug) $450.43
- SPRAVATO (Drug) $358.02
- BREZTRI (Drug) $336.19
- TRELEGY ELLIPTA (Drug) $331.69
- Kerendia (Drug) $328.90
- Tresiba (Drug) $324.16
- Victoza (Drug) $309.53
- ELIQUIS (Drug) $290.77
- Saxenda (Drug) $258.36
- JANUVIA (Drug) $254.46
- CHANTIX (Drug) $225.39
- ENTRESTO (Drug) $204.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Ontario
Renu Bhupathy, M.d, M.D
Family Medicine — Payments: $18,525
Harold Brown, Do, DO
Family Medicine — Payments: $15,100
Edward Adkins, M.d, M.D
Family Medicine — Payments: $14,470
Melissa Becker, Md, MD
Family Medicine — Payments: $5,465
Dr. Charles Ho, M.d, M.D
Family Medicine — Payments: $2,949
Judith Cabrera, Md, MD
Family Medicine — Payments: $2,574